|
|
|
Drug Information Association, EMEA, 7 West ferry Circus, Canary Wharf, London, United Kingdom
Aug 27 2008
This course will be the only training programme officially recognised by the EMEA. The EMEA will present successful candidates with a 'Certificate of Completion' based on a competency assessment at the end of the course. The EudraVigilance training programme is open to Contract Research Organisations (CROs), Consultants and other organisations with an interest in the EudraVigilance project. However, it should be noted that the persons attending the training will only be given access the EudraVigilance training environment for a period of two months. After this period the EudraVigilance system will only be available for these organisations if they act on behalf of a Marketing Authorisation Holder (MAH) or a Sponsor of a Clinical Trial and that this is notified to the EMEA in writing and through the EudraVigilance registration process.
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
Invited Speakers:
|
|
Calin A. Lungu, MD CEO Drug Development Consulting Services S.A. (DDCS)Luxembourg.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=14845&eventType=EudraVigilance
|
|
E-mail:
|
|
talana.bertschi@diaeurope.org
|
|
|
|
|
|
|
|